Aug. 16 at 3:25 AM
$ABCL
$ABCL represents the direction of the pharmaceutical industry moving toward precision medicine.
Imagine that past medicines were like bombs, while the large-molecule drugs represented by
$ABCL are like guided bombs. Using AI/DNA to precisely reach the target.
The total U.S. healthcare spending each year has already reached the extraordinarily massive 4 trillion USD.
However, within this enormous total expenditure, the share truly attributable to branded patented drugs is surprisingly less than 10%, and this proportion has barely changed over the past decade.
Modern DNA, PCR, CRISPR, AlphaFold, AI, to some extent, have the capability to create digital twins of human cells, thereby achieving precision treatment and delivery, and reducing costs across the entire healthcare industry.
